Good morning, and welcome to Biofrontera Inc.'s fourth quarter and full year 2025 financial results and business update conference call. Please note that certain information discussed during today's ...
C-PACE has matured from a policy incentive into a financing instrument with specific structural characteristics that either fit a given deal or don’t.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results